IP Verse

Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production - EP3581650

PATENT ANALYSIS

Patent Details

Grant Date
Dec 28, 2022
Company
UNIQURE BIOPHARMA B.V.
Oppositions

PFIZER INC.

More patents of Uniqure Biopharma B.V.

EP3581650

EP2337849

Want to monitor this patent?

Feel free to send us a message here and we will get back to you